Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.47 |
| ▸ | REN | P00797 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30862340 | 0.88 | REN (0.49) | OPRM1OPRD1REN | |
| SCHEMBL30862339 | 0.88 | REN (0.49) | OPRM1OPRD1REN | |
| SCHEMBL30832775 | 0.87 | OPRM1 (0.50) | OPRM1OPRD1 | |
| SCHEMBL30102196 | 0.82 | OPRM1 (0.58) | OPRM1OPRD1 | |
| SCHEMBL30829334 | 0.82 | CTSC (0.51) | OPRM1REN | |
| SCHEMBL29749240 | 0.80 | XIAP (0.41) | REN | |
| SCHEMBL31362679 | 0.80 | SLC6A2 (0.56) | OPRM1OPRD1REN | |
| SCHEMBL29777346 | 0.80 | OPRM1 (0.55) | OPRM1REN | |
| SCHEMBL31741272 | 0.79 | SLC6A2 (0.55) | OPRM1OPRD1REN | |
| SCHEMBL30108353 | 0.79 | OPRD1 (0.57) | OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041740-A1 | SKIN PEEL COMPOSITIONS | GLO PHARMA INC (US) | 2024-02-08 | — | — | US | disclosed |
| US-20230270635-A1 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | GLO PHARMA INC (US) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270635-A1 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | CUTA, GLA, LIPA | OPRM1 4861/4885OPRD1 4859/4885REN 4367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.